June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Induced ablation of scleral TGF-β signaling in mutant mice increases susceptibility to IOP-induced optic nerve damage
Author Affiliations & Notes
  • Magdalena Schneider
    Human Anatmoy and Embryology, Universitat Regensburg, Regensburg, Bayern, Germany
  • Andrea E. Dillinger
    Human Anatmoy and Embryology, Universitat Regensburg, Regensburg, Bayern, Germany
  • Ernst R. Tamm
    Human Anatmoy and Embryology, Universitat Regensburg, Regensburg, Bayern, Germany
  • Footnotes
    Commercial Relationships   Magdalena Schneider None; Andrea Dillinger None; Ernst Tamm None
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 14. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Magdalena Schneider, Andrea E. Dillinger, Ernst R. Tamm; Induced ablation of scleral TGF-β signaling in mutant mice increases susceptibility to IOP-induced optic nerve damage. Invest. Ophthalmol. Vis. Sci. 2022;63(7):14.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Axonal optic nerve (ON) damage in glaucoma is characteristically associated with increased amounts of active Transforming Growth Factor-β2 (TGF-β). Data from Quigley et al., (2015) indicate that TGF-β-signaling promotes IOP-induced ON damage, an effect that involves remodeling of the sclera. In the present study we investigated the functional role of scleral TGF-β-signaling in glaucoma. To this end we induced ocular hypertension (OHT) in mice with an inducible deficiency of TGF-β receptor type II (Tgfbr2) in scleral fibroblasts.

Methods : Tgfbr2fl/fl (T2fl/f) mice with a floxed allele of Tgfbr2 were crossed with Col1a2-CreER (Col1) mice. The mouse Col1a2 promoter is specifically active in fibroblasts, including those of the sclera. 14 days after Tamoxifen (TX) treatment OHT was induced in one eye, using the magnetic-microbead-model. IOP was measured by rebound tonometry. After six weeks of OHT, ON axons were PPD-stained and quantified. Somata of retinal ganglion cells (RGC) were quantified on whole mounts by RBPMS-staining. TGFBR2 and its mRNA were analyzed by western blotting and real time RT-PCR. IOP data was analyzed using one-way ANOVA, mRNA expression, protein synthesis, axon loss (Δaxons) and RGC loss (ΔRGC) were compared using two-tailed students t-tests.

Results : Following TX-treatment, scleral TGF-β RII mRNA and protein were significantly decreased (p ≤ 0.05). IOP was significantly elevated up to six weeks after injection. No difference in IOP of injected and un-injected eyes could be found between T2fl/fl and Col1xT2fl/fl animals at any timepoint. After six weeks of OHT, reduced numbers of ON axons (11±2%, n=17, p≤0.001) were seen in OHT eyes in comparison to contralateral eyes. Moreover, OHT also led to a decrease of retinal ganglion cell somata (22,87±9,87%; n = 10; p ≤ 0.001). Axon loss was significantly higher in mice with a fibroblast specific deficiency of TGF-β RII in comparison to control animals (Δaxons T2fl/fl = 9.29±5.76%; n=9; Δaxons Col1xT2fl/fl = 14.89±4.85%; n=8; p≤0.01). ΔRGC/mm2 was not changed in Col1xT2fl/fl mice (ΔRGC/mm2 T2fl/fl = 22.21±6.49%; n=5; ΔRGC/mm2 Col1xT2fl/fl = 22.37±15.09%; n=5; p=0.88).

Conclusions : We conclude that the ablation of scleral TGF-β signaling increases the susceptibility to IOP-induced optic nerve damage. Scleral TGF-β signaling in mutant mice appears to be beneficial for ON axon survival in experimentally induced OHT.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×